MW Smith & Nephew stock slumps after China-tied profit warning
Shares of medical equipment maker Smith & Nephew (UK:SN) tumbled 10% in early trade as the company slashed its earnings guidance. Citing worse-than-expected headwinds in China, it now sees underlying revenue growth for the year around 4.5%, versus 5% to 6% previously. That will translate into margins - it's now seeing "up to 50 basis points" of growth versus last year's 17.5%, versus previous guidance of at least 18%. For 2025, it's expecting to lift its margin to between 19% and 20%.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 31, 2024 04:13 ET (08:13 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments